Display options
Share it on

J Thorac Dis. 2019 Sep;11:S2034-S2035. doi: 10.21037/jtd.2019.08.98.

Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients.

Journal of thoracic disease

Dimitra Kerdidani, Sophia Magkouta, Maria Tsoumakidou

Affiliations

  1. Institute of Bioinnovation (IBI), Biomedical Sciences Research Center (BSRC) Alexander Fleming, Vari-Athens, Greece.
  2. 1st Department of Critical Care and Pulmonary Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 31632820 PMCID: PMC6783793 DOI: 10.21037/jtd.2019.08.98

[No abstract available.]

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

  1. J Thorac Dis. 2019 Mar;11(Suppl 3):S329-S330 - PubMed
  2. Am J Respir Crit Care Med. 2018 Oct 1;198(7):928-940 - PubMed
  3. Cancer Res. 2016 Jun 1;76(11):3189-99 - PubMed
  4. Oncotarget. 2017 Jun 28;8(54):93149-93155 - PubMed
  5. Thorax. 2019 Sep;74(9):858-864 - PubMed
  6. J Thorac Dis. 2019 Feb;11(2):382-385 - PubMed
  7. Eur Respir J. 2019 Jun 5;53(6):null - PubMed
  8. J Immunol. 2018 Sep 1;201(5):1558-1569 - PubMed
  9. Am J Respir Crit Care Med. 2016 Mar 15;193(6):642-51 - PubMed
  10. Am J Respir Crit Care Med. 2018 Feb 1;197(3):325-336 - PubMed

Publication Types